Mankind Pharma's Stock Performance Continues to Soar, Outperforming Sector and Market Averages

Oct 30 2024 09:35 AM IST
share
Share Via
Mankind Pharma, a leading pharmaceutical company in India, has shown a positive trend in its stock performance on October 30, 2024. With a gain of 3.38%, the stock is currently trading at Rs. 2630, outperforming the sector by 4.58%. This marks the second consecutive day of gains for the company, with a total rise of 7.79% in the past two days. The stock has also been performing well in comparison to its moving averages, indicating a strong upward trend. Mankind Pharma has also outperformed the Sensex in the past day and month, showcasing its resilience and stability in the market. While it has been recommended as a 'Hold' by MarketsMojo, investors should do their own research and consult with a financial advisor before making any investment decisions.

Mankind Pharma, a leading pharmaceutical company in India, has seen a positive trend in its stock performance on October 30, 2024. The stock has gained 3.38% and is currently trading at Rs. 2630, outperforming the sector by 4.58%. This marks the second consecutive day of gains for the company, with a total rise of 7.79% in the past two days.

The stock has also been performing well in comparison to its moving averages, trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This indicates a strong upward trend for Mankind Pharma.

In terms of overall market performance, Mankind Pharma has outperformed the Sensex by 2.88% in the past day and 3.12% in the past month. This showcases the company's resilience and stability in the face of market fluctuations.

Mankind Pharma, a largecap company in the pharmaceutical and drugs industry, has been recommended as a 'Hold' by MarketsMOJO. This is a testament to the company's strong fundamentals and potential for growth in the future.

Investors can keep an eye on Mankind Pharma as it continues to make positive strides in the market, but it is always important to do thorough research and consult with a financial advisor before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News